Interestingly, there was no significant difference in EphA2-negative melanoma BL6 cell-derived subcutaneous xenografts between the Eph-DC and unpulsed DC groups, suggesting vaccination with Eph-DCs provides specific antitumor effects against tumors positively express EphA2. The gene discussed is EPHA2; the disease is melanoma.